A. Mitsis, Michaela Kyriakou, Evi Christodoulou, S. Sakellaropoulos, P. Avraamides
{"title":"Antithrombotic Therapy Following Structural Heart Disease Interventions: Current Status and Future Directions","authors":"A. Mitsis, Michaela Kyriakou, Evi Christodoulou, S. Sakellaropoulos, P. Avraamides","doi":"10.31083/j.rcm2502060","DOIUrl":"https://doi.org/10.31083/j.rcm2502060","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"22 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139864360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Mitsis, Michaela Kyriakou, Evi Christodoulou, S. Sakellaropoulos, P. Avraamides
{"title":"Antithrombotic Therapy Following Structural Heart Disease Interventions: Current Status and Future Directions","authors":"A. Mitsis, Michaela Kyriakou, Evi Christodoulou, S. Sakellaropoulos, P. Avraamides","doi":"10.31083/j.rcm2502060","DOIUrl":"https://doi.org/10.31083/j.rcm2502060","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"62 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139804486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Establishment of a Comprehensive Cardiac Amyloidosis Center in a Community Hospital Setting","authors":"Prabin Phuyal, Sabahat Bokhari","doi":"10.31083/j.rcm2502061","DOIUrl":"https://doi.org/10.31083/j.rcm2502061","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"180 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139862864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Novel Predictive Model for Acute Kidney Injury Following Surgery of the Aorta","authors":"Mingjian Chen, Sheng Zhao, Pengfei Chen, Diming Zhao, Liqing Wang, Zhaoyang Chen","doi":"10.31083/j.rcm2502054","DOIUrl":"https://doi.org/10.31083/j.rcm2502054","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139806097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Novel Predictive Model for Acute Kidney Injury Following Surgery of the Aorta","authors":"Mingjian Chen, Sheng Zhao, Pengfei Chen, Diming Zhao, Liqing Wang, Zhaoyang Chen","doi":"10.31083/j.rcm2502054","DOIUrl":"https://doi.org/10.31083/j.rcm2502054","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139866375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"New Guidelines for Hypertension Diagnosis and Treatment: An European Perspective","authors":"Guido Grassi","doi":"10.31083/j.rcm2502055","DOIUrl":"https://doi.org/10.31083/j.rcm2502055","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139867307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"New Guidelines for Hypertension Diagnosis and Treatment: An European Perspective","authors":"Guido Grassi","doi":"10.31083/j.rcm2502055","DOIUrl":"https://doi.org/10.31083/j.rcm2502055","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"1993 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139807429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Attila Nemes, Á. Kormányos, Z. Ruzsa, A. Achim, N. Ambrus, C. Lengyel
{"title":"Right Ventricular Longitudinal Shortening is not Associated with Left Ventricular Rotational Mechanics in Healthy Adults - Insights from the Three-dimensional Speckle-tracking Echocardiographic MAGYAR-Healthy Study","authors":"Attila Nemes, Á. Kormányos, Z. Ruzsa, A. Achim, N. Ambrus, C. Lengyel","doi":"10.31083/j.rcm2502053","DOIUrl":"https://doi.org/10.31083/j.rcm2502053","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"15 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139811018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Attila Nemes, Á. Kormányos, Z. Ruzsa, A. Achim, N. Ambrus, C. Lengyel
{"title":"Right Ventricular Longitudinal Shortening is not Associated with Left Ventricular Rotational Mechanics in Healthy Adults - Insights from the Three-dimensional Speckle-tracking Echocardiographic MAGYAR-Healthy Study","authors":"Attila Nemes, Á. Kormányos, Z. Ruzsa, A. Achim, N. Ambrus, C. Lengyel","doi":"10.31083/j.rcm2502053","DOIUrl":"https://doi.org/10.31083/j.rcm2502053","url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"9 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139871074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Park, Pil‐Sung Yang, Daehoon Kim, J. Sung, E. Jang, H. Yu, Tae‐Hoon Kim, H. Pak, Moon‐Hyoung Lee, B. Joung
Background : Atrial fibrillation (AF) is an indicator of frailty in old patients. This study aimed to investigate the effect of frailty on the use of oral anticoagulants (OAC) and clinical outcomes in a nationwide cohort of patients with new-onset AF. Methods : This study included 451,368 participants without AF from the Korea National Health Insurance Service-Health Screening cohort between 2002 and 2009. The Hospital Frailty Risk Score was retrospectively calculated for each patient using all available International Classification of Disease 10th revision diagnostic codes. According to the aggregate score, patients were divided into two groups: the participants without frailty ( < 5 points) and the participants with frailty ( ≥ 5 points). The primary outcome was death from any cause, and the secondary outcomes were cardiovascular death, ischemic stroke, major bleeding, and heart failure admission. Results : With up to 7.2 ± 1.5 years of follow-up, 11,953 participants (median age, 67 [interquartile range, 59.5–74.5] years; 7200 [60.2%] males) developed new-onset AF. Among the patients with AF, 3224 (26.9%) had frailty. Frailty was significantly associated with old age, female sex, polypharmacy, and other comorbidities. In patients with AF, frailty was negatively associated with OAC prescription after new-onset AF ( p < 0.001). Compared to patients without frailty, patients with frailty had a significantly higher incidence and risk of all-cause death (hazard ratio [HR] 2.88, 95% confidence interval [CI] 2.65–3.14), cardiovascular death (HR 2.42, 95% CI 2.10–2.80), ischemic stroke (HR 2.25, 95% CI 2.02–2.51), major bleeding (HR 2.44, 95% CI 2.17–2.73), and heart failure admission (HR 1.29, 95% CI 1.09–1.52). In subgroup analysis, when compared to the non-OAC group, the risks associated with frailty were significantly lower in the OAC group for all-cause death, cardiovascular death, ischemic stroke, and heart failure admission. Conclusions : Frailty was negatively associated with the use of OAC and was a predictor of poor prognosis owing to the association of frailty with death, thromboembolic events, bleeding, and heart failure admission. However, OAC use was associated with lower risks related to frailty for all-cause death and major adverse cardiovascular events in patients with AF.
{"title":"All-Cause Death and Major Adverse Events in Atrial Fibrillation with Frailty: Observations from the Korea National Health Insurance Service Data","authors":"J. Park, Pil‐Sung Yang, Daehoon Kim, J. Sung, E. Jang, H. Yu, Tae‐Hoon Kim, H. Pak, Moon‐Hyoung Lee, B. Joung","doi":"10.31083/j.rcm2502052","DOIUrl":"https://doi.org/10.31083/j.rcm2502052","url":null,"abstract":"Background : Atrial fibrillation (AF) is an indicator of frailty in old patients. This study aimed to investigate the effect of frailty on the use of oral anticoagulants (OAC) and clinical outcomes in a nationwide cohort of patients with new-onset AF. Methods : This study included 451,368 participants without AF from the Korea National Health Insurance Service-Health Screening cohort between 2002 and 2009. The Hospital Frailty Risk Score was retrospectively calculated for each patient using all available International Classification of Disease 10th revision diagnostic codes. According to the aggregate score, patients were divided into two groups: the participants without frailty ( < 5 points) and the participants with frailty ( ≥ 5 points). The primary outcome was death from any cause, and the secondary outcomes were cardiovascular death, ischemic stroke, major bleeding, and heart failure admission. Results : With up to 7.2 ± 1.5 years of follow-up, 11,953 participants (median age, 67 [interquartile range, 59.5–74.5] years; 7200 [60.2%] males) developed new-onset AF. Among the patients with AF, 3224 (26.9%) had frailty. Frailty was significantly associated with old age, female sex, polypharmacy, and other comorbidities. In patients with AF, frailty was negatively associated with OAC prescription after new-onset AF ( p < 0.001). Compared to patients without frailty, patients with frailty had a significantly higher incidence and risk of all-cause death (hazard ratio [HR] 2.88, 95% confidence interval [CI] 2.65–3.14), cardiovascular death (HR 2.42, 95% CI 2.10–2.80), ischemic stroke (HR 2.25, 95% CI 2.02–2.51), major bleeding (HR 2.44, 95% CI 2.17–2.73), and heart failure admission (HR 1.29, 95% CI 1.09–1.52). In subgroup analysis, when compared to the non-OAC group, the risks associated with frailty were significantly lower in the OAC group for all-cause death, cardiovascular death, ischemic stroke, and heart failure admission. Conclusions : Frailty was negatively associated with the use of OAC and was a predictor of poor prognosis owing to the association of frailty with death, thromboembolic events, bleeding, and heart failure admission. However, OAC use was associated with lower risks related to frailty for all-cause death and major adverse cardiovascular events in patients with AF.","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"26 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140482515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：